Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Thyroid Carcinoma, Anaplastic

quinazolines has been researched along with Thyroid Carcinoma, Anaplastic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonelli, A; Baldini, E; Bocci, G; Di Desidero, T; Elia, G; Fallahi, P; Ferrari, SM; Fioravanti, A; La Motta, C; Materazzi, G; Miccoli, P; Orlandi, P; Paparo, SR; Patrizio, A; Piaggi, S; Ragusa, F; Ruffilli, I; Ulisse, S1
Chi, WM; Hsieh, WS; Hsu, KW; Huang, LC; Lee, AW; Lee, CH; Lin, CL; Lin, CY; Liu, WN; Tam, KW; Yang, JM1
Bartsch, DK; Doll, D; Greene, BH; Hoffmann, S; Khoruzhyk, M; Ramaswamy, A; Roth, S; Wunderlich, A1
Antonelli, A; Arlot-Bonnemains, Y; Baldini, E; Bononi, M; D'Armiento, M; Gnessi, L; Moretti, C; Morrone, S; Prinzi, N; Sorrenti, S; Tuccilli, C; Ulisse, S1
Boufraqech, M; Kebebew, E; Lake, R; Zhang, L1
Abagnale, A; Barbato, S; Botta, G; Chieffi, P; Libertini, S; Passaro, C; Portella, G1
Bankson, JA; Chen, Y; Frederick, MJ; Galer, CE; Gule, MK; Henderson, YC; Jasser, SA; Lai, SY; Milas, ZL; Myers, JN; Sano, D; Schwartz, DL; Zhao, M; Zhou, G1

Other Studies

7 other study(ies) available for quinazolines and Thyroid Carcinoma, Anaplastic

ArticleYear
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.
    Oncology reports, 2018, Volume: 39, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperidines; Proto-Oncogene Proteins c-akt; Quinazolines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Treatment Outcome; Xenograft Model Antitumor Assays

2018
CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer.
    Disease markers, 2018, Volume: 2018

    Topics: Afatinib; Antineoplastic Agents; Cell Cycle; Cell Death; Cell Line, Tumor; CRISPR-Cas Systems; ErbB Receptors; Gene Editing; Humans; Protein Kinase Inhibitors; Quinazolines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms

2018
Pretherapeutic drug evaluation by tumor xenografting in anaplastic thyroid cancer.
    The Journal of surgical research, 2013, Volume: 185, Issue:2

    Topics: Animals; Apoptosis; Benzazepines; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Quinazolines; Random Allocation; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Treatment Outcome; Xenograft Model Antitumor Assays

2013
Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
    Endocrine-related cancer, 2014, Volume: 21, Issue:5

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Aurora Kinase A; Aurora Kinase B; Azepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Organophosphates; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Thyroid Carcinoma, Anaplastic

2014
Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.
    Oncotarget, 2016, Mar-29, Volume: 7, Issue:13

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mutation; Oligopeptides; Poly(ADP-ribose) Polymerases; Quinazolines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms

2016
AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947.
    Endocrine-related cancer, 2011, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; Combined Modality Therapy; Drug Synergism; Female; Humans; Mice; Mice, Nude; Oncolytic Virotherapy; Oncolytic Viruses; Organophosphates; Protein Kinase Inhibitors; Quinazolines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays

2011
Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-15, Volume: 17, Issue:8

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Humans; Immunoblotting; In Situ Nick-End Labeling; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Piperidines; Platelet Endothelial Cell Adhesion Molecule-1; Quinazolines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2011